These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1316 related articles for article (PubMed ID: 30814252)

  • 1. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
    Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
    J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical imaging of evolving amyloid plaque pathology and associated Aβ peptide aggregation in a transgenic mouse model of Alzheimer's disease.
    Michno W; Wehrli P; Meier SR; Sehlin D; Syvänen S; Zetterberg H; Blennow K; Hanrieder J
    J Neurochem; 2020 Mar; 152(5):602-616. PubMed ID: 31605538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal Chemical Imaging of Amyloid Plaque Polymorphism Reveals Aβ Aggregation Dependent Anionic Lipid Accumulations and Metabolism.
    Michno W; Kaya I; Nyström S; Guerard L; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
    Anal Chem; 2018 Jul; 90(13):8130-8138. PubMed ID: 29856605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical signatures delineate heterogeneous amyloid plaque populations across the Alzheimer's disease spectrum.
    Koutarapu S; Ge J; Dulewicz M; Srikrishna M; Szadziewska A; Wood J; Blennow K; Zetterberg H; Michno W; Ryan NS; Lashley T; Savas J; Schöll M; Hanrieder J
    bioRxiv; 2024 Jun; ():. PubMed ID: 38895368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
    Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
    J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineating Amyloid Plaque Associated Neuronal Sphingolipids in Transgenic Alzheimer's Disease Mice (tgArcSwe) Using MALDI Imaging Mass Spectrometry.
    Kaya I; Brinet D; Michno W; Syvänen S; Sehlin D; Zetterberg H; Blennow K; Hanrieder J
    ACS Chem Neurosci; 2017 Feb; 8(2):347-355. PubMed ID: 27984697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GM1 locates to mature amyloid structures implicating a prominent role for glycolipid-protein interactions in Alzheimer pathology.
    Michno W; Wehrli PM; Zetterberg H; Blennow K; Hanrieder J
    Biochim Biophys Acta Proteins Proteom; 2019 May; 1867(5):458-467. PubMed ID: 30273679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry.
    Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M
    Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural amyloid plaque polymorphism is associated with distinct lipid accumulations revealed by trapped ion mobility mass spectrometry imaging.
    Michno W; Wehrli PM; Koutarapu S; Marsching C; Minta K; Ge J; Meyer SW; Zetterberg H; Blennow K; Henkel C; Oetjen J; Hopf C; Hanrieder J
    J Neurochem; 2022 Feb; 160(4):482-498. PubMed ID: 34882796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shedding Light on the Molecular Pathology of Amyloid Plaques in Transgenic Alzheimer's Disease Mice Using Multimodal MALDI Imaging Mass Spectrometry.
    Kaya I; Zetterberg H; Blennow K; Hanrieder J
    ACS Chem Neurosci; 2018 Jul; 9(7):1802-1817. PubMed ID: 29648443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical traits of cerebral amyloid angiopathy in familial British-, Danish-, and non-Alzheimer's dementias.
    Michno W; Koutarapu S; Camacho R; Toomey C; Stringer K; Minta K; Ge J; Jha D; Fernandez-Rodriguez J; Brinkmalm G; Zetterberg H; Blennow K; Ryan NS; Lashley T; Hanrieder J
    J Neurochem; 2022 Nov; 163(3):233-246. PubMed ID: 36102248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass Spectrometry Imaging in Alzheimer's Disease.
    Ikegawa M; Kakuda N; Miyasaka T; Toyama Y; Nirasawa T; Minta K; Hanrieder J
    Brain Connect; 2023 Aug; 13(6):319-333. PubMed ID: 36905365
    [No Abstract]   [Full Text] [Related]  

  • 14. Diversity in Aβ deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis.
    Xu G; Fromholt SE; Chakrabarty P; Zhu F; Liu X; Pace MC; Koh J; Golde TE; Levites Y; Lewis J; Borchelt DR
    Acta Neuropathol Commun; 2020 Apr; 8(1):43. PubMed ID: 32252825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlative Chemical Imaging Identifies Amyloid Peptide Signatures of Neuritic Plaques and Dystrophy in Human Sporadic Alzheimer's Disease.
    Koutarapu S; Ge J; Jha D; Blennow K; Zetterberg H; Lashley T; Michno W; Hanrieder J
    Brain Connect; 2023 Jun; 13(5):297-306. PubMed ID: 36074939
    [No Abstract]   [Full Text] [Related]  

  • 16. Diversity of senile plaques in Alzheimer's disease as revealed by a new monoclonal antibody that recognizes an internal sequence of the Abeta peptide.
    Rábano A; Jiménez-Huete A; Acevedo B; Calero M; Ghiso J; Valdés I; Gavilondo J; Frangione B; Méndez E
    Curr Alzheimer Res; 2005 Oct; 2(4):409-17. PubMed ID: 16248846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases.
    Wirths O; Bethge T; Marcello A; Harmeier A; Jawhar S; Lucassen PJ; Multhaup G; Brody DL; Esparza T; Ingelsson M; Kalimo H; Lannfelt L; Bayer TA
    J Neural Transm (Vienna); 2010 Jan; 117(1):85-96. PubMed ID: 19823761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Label-free vibrational imaging of different Aβ plaque types in Alzheimer's disease reveals sequential events in plaque development.
    Röhr D; Boon BDC; Schuler M; Kremer K; Hoozemans JJM; Bouwman FH; El-Mashtoly SF; Nabers A; Großerueschkamp F; Rozemuller AJM; Gerwert K
    Acta Neuropathol Commun; 2020 Dec; 8(1):222. PubMed ID: 33308303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.
    Gkanatsiou E; Sahlin C; Portelius E; Johannesson M; Söderberg L; Fälting J; Basun H; Möller C; Odergren T; Zetterberg H; Blennow K; Lannfelt L; Brinkmalm G
    Neurosci Lett; 2021 May; 754():135894. PubMed ID: 33848613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-truncated Aβ
    Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
    Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.